Otospondylomegaepiphyseal dysplasia
Otospondylomegaepiphyseal dysplasia (OSMED) is a rare genetic disorder that affects the development of the skeleton, hearing, and vision. It is characterized by short stature, severe hearing loss, and problems with vision. The condition is caused by mutations in the COL11A2 gene.
Symptoms and Signs[edit]
The most common symptoms of OSMED include short stature, severe hearing loss, and problems with vision. Other symptoms may include joint pain, skeletal abnormalities, and facial deformities. The severity of symptoms can vary greatly among individuals with the condition.
Causes[edit]
OSMED is caused by mutations in the COL11A2 gene. This gene provides instructions for making a protein that is essential for the normal development of cartilage and the formation of collagen, a protein that provides structure and strength to tissues and organs throughout the body. Mutations in the COL11A2 gene disrupt the normal development of cartilage and collagen, leading to the symptoms of OSMED.
Diagnosis[edit]
Diagnosis of OSMED is based on the presence of characteristic symptoms and signs. Genetic testing can confirm the diagnosis by identifying a mutation in the COL11A2 gene.
Treatment[edit]
There is currently no cure for OSMED. Treatment is focused on managing symptoms and improving quality of life. This may include hearing aids for hearing loss, physical therapy for joint pain and mobility issues, and surgery to correct skeletal abnormalities.
Prognosis[edit]
The prognosis for individuals with OSMED varies depending on the severity of symptoms. With appropriate management and treatment, many individuals with the condition can lead productive lives.
See Also[edit]
-
Otospondylomegaepiphyseal dysplasia
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
